There’s never a good time or place to be diagnosed with cancer. But some times and places are worse than others.
Right now, cancer patients in Europe face record-setting wait times when seeking cutting-edge treatment. Once European regulators approve a new oncology drug, it takes 655 days, on average, for Europe’s government-run insurance systems to start offering it to patients.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
